Spotlight on atezolizumab and its potential in the treatment of advanced urothelial bladder cancer

Metastatic urothelial carcinoma of the bladder is an aggressive malignancy with poor prognosis, reflecting a lack of effective systemic therapies. The current standard of care includes multiagent platinum-based chemotherapy; however a majority of patients do not respond to treatment and most eventua...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Onco Targets Ther
Hlavní autoři: Aydin, Ahmet Murat, Woldu, Solomon L, Hutchinson, Ryan C, Boegemann, Martin, Bagrodia, Aditya, Lotan, Yair, Margulis, Vitaly, Krabbe, Laura-Maria
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2017
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5352238/
https://ncbi.nlm.nih.gov/pubmed/28331342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S109453
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky